Chromosomal instability in chromosome band 12p13: Multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones

Leukemia

Volumn 15, Issue 8, 2001, Pages 1193-1202

  Sato, Y ^a   Kobayashi, H ^b   Suto, Y ^c   Olney, H J ^d   Davis, E M ^d   Super, H Gill ^d   Espinosa III, R ^d   Le Beau, M M ^d   Rowley, J D ^d  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c Aomori Municipal Hospital   (Japan)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

12p13 rearrangements; Chromosomal instability; FISH; Hematologic malignancies; KIP1 CDKN1B; TEL ETV6

Indexed keywords

ANTINEOPLASTIC AGENT; MUTAGENIC AGENT;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; CANCER SURVIVAL; CHROMOSOME 12P; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME BREAKAGE; CHROMOSOME INSERTION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CLONE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC STABILITY; HUMAN; KARYOTYPE; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METAPHASE; MUTAGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

EID: 0034882524     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402188     Document Type: Article

References (36)

1. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia
2. TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia
3. Fluorescence in situ hybridization analyses of hematologic malignancies reveal frequent cytogenetically unrecognized 12p rearrangements
4. Fluorescence in situ hybridization characterization of new translocation involving TEL (ETV6) in a wide spectrum of hematologic malignancies
5. The role of chromosomal translocations in leukemia
6. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
7. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
8. The novel activation of ABL by fusion to an ets-related gene, TEL
9. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation
10. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
11. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
12. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
13. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
14. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma
15. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma
16. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion
17. Identification of eight new translocations involving TEL/ETV6 in hematological malignancies using FISH and spectral karyotyping
18. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies
19. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: Hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p)
20. Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL(ETV6) is involved in only one half
21. Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies
22. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in a various 12p aberrations in different hematological malignancies
23. Cytogenetic analysis of hematological malignant diseases
24. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias
25. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases
26. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome
27. Identification of cytogenetically undetected 12p13 translocations and associated deletions with fluorescence in situ hybridization
28. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7
29. Chromosome translocations: Dangerous liaisons
30. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis
31. Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML)
32. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
33. Large deletions 5' to ETO breakpoint were observed in 10% of patients with t(8;21)-positive AML
34. Frequent jumping translocation of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias